Endologix Inc (ELGX) - Product Pipeline Analysis, 2019 Update

Summary

Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive devices in treatment of aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The companys AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform and Ovation system. The companys EVAR products include AFX endovascular AAA system. Its Ovation system consists of a low-permeability polytetrafluoroethylene and a radiopaque nitinol suprarenal stent with integral anchors. EVAS products comprise Nellix endovascular aneurysm sealing system. It has manufacturing facility in Irvine and Santa Rosa, California. The company sells products in the US and six other countries through direct sales force. It also sells products through third-party distributors and agents in Asia Pacific, Latin America, Europe and other targeted international geographies. Endologix is headquartered in Irvine, California, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Endologix Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company




Endologix Inc Company Overview
Endologix Inc Company Snapshot
Endologix Inc Pipeline Products and Ongoing Clinical Trials Overview
Endologix Inc Pipeline Analysis Overview
Business Description
Endologix Inc - Key Facts
Endologix Inc - Major Products and Services
Endologix Inc Pipeline Products by Development Stage
Endologix Inc Ongoing Clinical Trials by Trial Status
Endologix Inc Pipeline Products Overview
AFX3
AFX3 Product Overview
AFX4
AFX4 Product Overview
Nellix 3.5
Nellix 3.5 Product Overview
Nellix CHEVAS
Nellix CHEVAS Product Overview
Nellix EVAS System
Nellix EVAS System Product Overview
Nellix EVAS System Clinical Trial
Nellix With Snorkels
Nellix With Snorkels Product Overview
Next Gen EVAS
Next Gen EVAS Product Overview
Ovation Alto System
Ovation Alto System Product Overview
Ovation Thoracic Stent Graft System
Ovation Thoracic Stent Graft System Product Overview
Paravisceral System
Paravisceral System Product Overview
Ventana 2
Ventana 2 Product Overview
Xpand BX Covered Stent
Xpand BX Covered Stent Product Overview
Xpand BX Covered Stent Clinical Trial
Endologix Inc - Key Competitors
Endologix Inc - Key Employees
Endologix Inc - Key Employee Biographies
Endologix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Endologix Inc, Recent Developments
May 02, 2019: Endologix reports first quarter 2019 financial results
May 01, 2019: Endologix announces recall of Nellix Endovascular Aneurysm Sealing (EVAS) System
Feb 25, 2019: Endologix announces fourth quarter and fiscal year 2018 financial results
Jan 25, 2019: Nellix Endovascular Aneurysm Sealing (EVAS) System - device recall and enhanced patient surveillance (MDA/2019/002)
Jan 22, 2019: Endologix provides update on previously announced voluntary Nellix System recall
Jan 10, 2019: Endologix names John D. Zehren as Chief Commercial Officer
Jan 07, 2019: Endologix Announces Fourth Quarter and Full-Year 2018 Preliminary Financial Results and Provides 2019 Financial Guidance
Jan 04, 2019: Endologix takes decisive action to optimize patient outcomes by ensuring Nellix System used only within current indications
Nov 15, 2018: Endologix honors innovators of aortic therapy at VEITHsymposium
Nov 01, 2018: Endologix reports third quarter 2018 financial results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Endologix Inc Pipeline Products and Ongoing Clinical Trials Overview
Endologix Inc Pipeline Products by Equipment Type
Endologix Inc Pipeline Products by Indication
Endologix Inc Ongoing Clinical Trials by Trial Status
Endologix Inc, Key Facts
Endologix Inc, Major Products and Services
Endologix Inc Number of Pipeline Products by Development Stage
Endologix Inc Pipeline Products Summary by Development Stage
Endologix Inc Ongoing Clinical Trials by Trial Status
Endologix Inc Ongoing Clinical Trials Summary
AFX3 - Product Status
AFX3 - Product Description
AFX4 - Product Status
AFX4 - Product Description
Nellix 3.5 - Product Status
Nellix 3.5 - Product Description
Nellix CHEVAS - Product Status
Nellix CHEVAS - Product Description
Nellix EVAS System - Product Status
Nellix EVAS System - Product Description
Nellix EVAS System - Multicenter, Observational, Post-market, Real World Registry to Assess Outcomes of Patients Treated with the Nellix System for Endovascular Abdominal Aortic Aneurysm Repair
Nellix EVAS System - Multicenter, Observational, Registry to Assess Outcomes of Patients Treated With the CE Marked Nellix System for Endovascular Abdominal Aortic Aneurysm Repair
Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study: EVAS 2 Confirmatory IDE Study
Nellix EVAS System - Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System: A Pivotal and Continued Access Study
Nellix EVAS System - Study of a Sealing Type Stent-graft For Abdominal Aortic Aneurysm
Nellix With Snorkels - Product Status
Nellix With Snorkels - Product Description
Next Gen EVAS - Product Status
Next Gen EVAS - Product Description
Ovation Alto System - Product Status
Ovation Alto System - Product Description
Ovation Thoracic Stent Graft System - Product Status
Ovation Thoracic Stent Graft System - Product Description
Paravisceral System - Product Status
Paravisceral System - Product Description
Ventana 2 - Product Status
Ventana 2 - Product Description
Xpand BX Covered Stent - Product Status
Xpand BX Covered Stent - Product Description
Xpand BX Covered Stent - Prospective, Multicenter, Single Arm Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms
Endologix Inc, Key Employees
Endologix Inc, Key Employee Biographies
Endologix Inc, Subsidiaries
Glossary

List Of Figures


Endologix Inc Pipeline Products by Equipment Type
Endologix Inc Pipeline Products by Development Stage
Endologix Inc Ongoing Clinical Trials by Trial Status

Endologix LLC - Strategic SWOT Analysis Review

Endologix LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

Endologix Inc (ELGX) - Product Pipeline Analysis, 2020 Update

Endologix, Inc (Endologix) is a medical device company. It develops, manufactures and markets minimally invasive devices in treatment of aortic diseases. The company incorporates its patented technology for the treatment

USD 750 View Report

Endologix Inc (ELGX) - Product Pipeline Analysis, 2020 Update

Endologix, Inc (Endologix) is a medical device company. It develops, manufactures and markets minimally invasive devices in treatment of aortic diseases. The company incorporates its patented technology for the treatment

USD 750 View Report

Endologix Inc (ELGX) - Financial and Strategic SWOT Analysis Review

Endologix Inc (ELGX) - Financial and Strategic SWOT Analysis Review

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available